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Human Co-Infection 
with Avian and  
Seasonal Influenza 
Viruses, China
To the Editor: In April 2013, a 
case of co-infection with avian-origin 
influenza A(H7N9) virus and sea-
sonal influenza A(H3N2) virus was 
reported in Jiangsu Province, China 
(1). This case raised concern over 
the possible occurrence of new reas-
sortants with enhanced transmissibil-
ity among humans. Because of the 
nature of the dynamic reassortment 
of A(H7N9) virus with A(H9N2) vi-
rus in the environment and in poultry 
(2,3), close surveillance for possible 
new reassortment in human patients 
with A(H7N9) infection is needed. 
We report co-infection in 2 patients 
in Hangzhou, the capital Zhejiang 
Province, China, in January 2014. 
The co-infections involved influ-
enza A(H7N9) virus and a seasonal 
A(H1N1)pdm09 virus (1 patient) or a 
seasonal influenza B virus (1 patient).
Of 60 patients with laboratory-
confirmed influenza A(H7N9) infec-
tions in Hangzhou in April 2013 and 
in January–February 2014, testing of 
pharyngeal swab samples indicated 
that 2 patients were also positive for 
seasonal influenza virus. The pharyn-
geal samples were tested by real-time 
reverse transcription PCR according 
to protocols provided by the Chinese 
National Influenza Center. Informed 
consent for this study was provided by 
each patient’s spouse. 
On January 6, 2014, patient 1 
(male, 58 years of age), a resident of 
Xiaoshan District, had a high fever 
(39.6°C) and a cough; at a hospital, he 
received a diagnosis of severe acute 
interstitial pneumonia. The patient 
had a history of chronic myelogenous 
leukemia; his history of exposure to 
live poultry was not clear. On January 
13, infection with influenza A(H7N9) 
virus was laboratory confirmed; viral 
RNA from a pharyngeal swab sample 
collected before oseltamivir treat-
ment was positive for the following: 
influenza A virus (cycle threshold 
[Ct] = 26), H7 (Ct = 27), N9 (Ct = 26), 
influenza A(H1N1)pdm09 virus H1 
(Ct = 30), and N1 (Ct = 30). The 2 
viruses were named A/Hangzhou/10–
1/2014(H7N9) and A/Hangzhou/10–
2/2014(H1N1)pdm09. The patient 
received oseltamivir while in the hos-
pital but died on January 18.
On January 5, patient 2 (male, 54 
years of age), also from Xiaoshan Dis-
trict, had fever and a cough; at a hos-
pital, he received a diagnosis of severe 
acute pneumonia. He had a history of 
aplastic anemia and had been exposed 
to live poultry 1 week before symptom 
onset. On January 18, infection with in-
fluenza A(H7N9) virus was laboratory 
confirmed. Viral RNA from a pharyn-
geal swab sample collected before os-
eltamivir treatment was positive for the 
following: influenza A virus (Ct = 22), 
H7 (Ct = 23), N9 (Ct = 22), and influen-
za B virus (Ct = 22). The viruses were 
named A/Hangzhou/17–1/2014(H7N9) 
and B/Hangzhou/17–2/2014. This pa-
tient received oseltamivir but died on 
January 22.
The hemagglutinin (HA) and 
neuraminidase (NA) sequences of 
viruses from these 2 patients were 
determined by Sanger sequencing. 
The specific primers used are listed 
in online Technical Appendix Ta-
ble 1 (http://wwwnc.cdc.gov/EID/
article/20/11/14-0897-Techapp1.
pdf). The accession numbers of these 
sequences and the reference sequenc-
es for phylogenetic analyses are 
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listed in online Technical Appendix 
Table 2. Phylogenetic analyses (4) re-
vealed that these 2 influenza A(H7N9) 
viruses were clustered into the 
clade of A/Shanghai/2/2013(H7N9)-
like viruses (Figure). Some amino 
acid features within the HA and NA of 
these 2 viruses were the same as those 
in the A/Shanghai/2/2013(H7N9) 
strain: L226 and G228 in HA, be-
lieved to control host receptor 
specificity; the cleavage site in HA, 
relevant for virulence; a deletion 
in NA stalk (position 69–73), as-
sociated with the adaption to gal-
linaceous hosts; and R294 in NA, 
related to virus sensitivity to oselta-
mivir (5). The HA and NA sequences 
of A/Hangzhou/10–2/2014(H1N1)
pdm09 and B/Hangzhou/17–2/2014 
were very close to those of A(H1N1)
pdm09 virus and B/Yamagata-lineage 
viruses that had recently circulated in 
China (6,7).
Co-infection with A(H7N9) vi-
rus and seasonal influenza viruses is 
probably associated with the overlap 
of A(H7N9) virus and seasonal virus 
circulation in both time and space and 
with  increased prevalence of influ-
enza virus infections within the popu-
lation. From November 2012 through 
March 2014, outbreaks of A(H7N9) 
infection (in April 2013 and in Janu-
ary–February 2014) were concurrent 







virus infections in Hangzhou (online 
Technical Appendix Figure). Prompt 
control of A(H7N9) infection out-
breaks and vaccination against sea-
sonal influenza viruses could reduce 
the potential for co-infections with 
A(H7N9) virus and seasonal viruses.
Taken together with the previous 
finding of human co-infection with 
A(H7N9) virus and A(H3N2) virus 
(1), our results show that human co-
infection with A(H7N9) virus and 
each of the 3 seasonal influenza vi-
ruses currently circulating worldwide 
can occur. Avian influenza viruses, 
including A(H7N9), preferentially 
replicate in the lower respiratory tract 
of humans (8,9). In contrast, seasonal 
influenza viruses preferentially infect 
the upper respiratory tract of humans 
(10). Coexistence of A(H7N9) virus 
with either A(H1N1)pdm09 virus or 
influenza B virus in the pharyngeal 
swab samples from 2 patients suggests 
that the upper respiratory tract could 
provide a location for the A(H7N9) 
virus to reassort with other influenza 
viruses. The possibility that season-
al influenza viruses might provide 
some gene segments that increase the 
human-to-human transmissibility of 
possible new reassortants is cause for 
concern. For detection of such new 
influenza virus reassortants, extensive 
surveillance to identify influenza virus 
co-infections is necessary.
This work was supported by the 
Hangzhou Key Medicine Discipline Fund 
for Public Health Laboratory, sponsored by 
the Hangzhou government, and the S&T 
Innovation Group of Key Technology for 
Public Health Surveillance and Emergency 
Preparedness and Response, sponsored by 
the Zhejiang government (2011R50021). 
Jun Li, Yu Kou, Xinfen Yu, 
Yongxiang Sun, Yinyan Zhou, 
Xiaoying Pu, Tao Jin,  
Jingcao Pan, and George F. Gao
Author	 affiliations:	 Hangzhou	 Center	 for	










  1. Zhu Y, Qi X, Cui L, Zhou M, Wang H. 
Human co-infection with novel avian 
influenza A H7N9 and influenza A H3N2 
viruses in Jiangsu province, China. 
Lancet. 2013;381:2134 http://dx.doi.org/ 
10.1016/S0140-6736(13)61135-6.
  2. Yu X, Jin T, Cui Y, Pu X, Li J, Xu J, et al. 
Influenza H7N9 and H9N2 viruses: coex-
istence in poultry linked to human H7N9 
infection and genome characteristics. 
J Virol. 2014;88:3423–31 http://dx.doi.
org/10.1128/JVI.02059-13.
  3. Cui L, Liu D, Shi W, Pan J, Qi X, Li X, 
et al. Dynamic reassortments and genetic 
heterogeneity of the human-infecting in-
fluenza A (H7N9) virus. Nat Commun. 
2014;5:3142.  
  4. Tamura K, Peterson D, Peterson N, 
Stecher G, Nei M, Kumar S. MEGA5: 
molecular evolutionary genetics analysis 
using maximum likelihood, evolution-
ary distance, and maximum parsimony 
methods. Mol Biol Evol. 2011;28:2731–9. 
http://dx.doi.org/10.1093/molbev/msr121
  5. Gao R, Cao B, Hu Y, Feng Z, Wang D, 
Hu W, et al. Human infection with a novel 
avian-origin influenza A (H7N9) virus. 
N Engl J Med. 2013;368:1888–97 http://
dx.doi.org/10.1056/NEJMoa1304459.
  6. Li J, Shao TJ, Yu XF, Pan JC, Pu XY, 
Wang HQ, et al. Molecular evolution of HA 
gene of the influenza A H1N1 pdm09 strain 
during the consecutive seasons 2009–2011 
in Hangzhou, China: several immune-
escape variants without positively selected 
sites. J Clin Virol. 2012;55:363–6 http://
dx.doi.org/10.1016/j.jcv.2012.08.006.
  7. Tan Y, Guan W, Lam TT, Pan S, Wu S, 
Zhan Y, et al. Differing epidemiological 
dynamics of influenza B virus lineages in 
Guangzhou, southern China, 2009–2010. 
J Virol. 2013;87:12447–56 http://dx.doi.
org/10.1128/JVI.01039-13.
  8. Chen Y, Liang W, Yang S, Wu N, Gao H, 
Sheng J, et al. Human infections with the 
emerging avian influenza A H7N9 virus 
from wet market poultry: clinical analy-
sis and characterisation of viral genome. 
Lancet. 2013;381:1916–25 http://dx.doi.
org/10.1016/S0140-6736(13)60903-4.
  9. Chan MC, Chan RW, Chan LL, Mok CK, 
Hui KP, Fong JH, et al. Tropism and in-
nate host responses of a novel avian 
influenza A H7N9 virus: an analysis of 
ex-vivo and in-vitro cultures of the hu-
man respiratory tract. Lancet Respir Med. 
2013;1:534–42 http://dx.doi.org/10.1016/
S2213-2600(13)70138-3.
10. Couceiro JN, Paulson JC, Baum LG. 
Influenza virus strains selectively recog-
nize sialyloligosaccharides on human re-
spiratory epithelium; the role of the host 
cell in selection of hemagglutinin recep-
tor specificity. Virus Res. 1993;29:155–
65 http://dx.doi.org/10.1016/0168-1702 
(93)90056-S.
Address for correspondence: Jingcao Pan, 
Microbiology Laboratory, Hangzhou Center 
for Disease Control and Prevention, Room 221, 
Building 5, Mingshi Rd, Jianqiao Zhen, Jianggan 




Species Related to 
Global Fish Trade, 
Europe
To the Editor: Diphylloboth-
riosis, infection by tapeworms of the 
genus Diphyllobothrium (Cestoda: Di-
phyllobothriidea) (1), is a well-known 
disease of humans. In Europe, infec-
tions caused by 3 species of Diphyllo-
bothrium have recently been reported 
in humans: D. latum is considered to 
be the principal species infecting per-
sons in Europe (1); 4 cases of D. den-
driticum infection and 6 cases of D. 
nihonkaiense infection have also been 
reported (2,3). Except for those caused 
by D. latum, which is autochthonous 
in northeastern Europe and subalpine 
lakes, most of the cases in Europe have 
been imported or caused by consump-
tion of fish imported from areas to 
which the parasites are endemic (1,3,4).
Diphyllobothriosis is not endemic 
to Spain, but 7 cases of D. latum 
